SYK logo

Stryker (SYK)

Profile

Full Name

Stryker Corporation

Ticker Symbol

SYK

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

http://www.stryker.com

Employees

53000

Key Details

Price

$362.97(+7.59%)

Market cap

$138.50B(Mega cap)

Last Dividend

$0.84

TTM Dividend yield

0.90%

Annual revenue

$22.59B(+10.23% YoY)

Annual EPS

$7.76(-5.94% YoY)

PE ratio

46.77

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$362.97
SYK price is $362.97

30-Day Relative Volume

1.67
SYK 30-day relative volume is 1.67

Price Performance

Price Most recent change

+7.59%
SYK price was up +7.59% on Apr 9, 2025

Price YTD change

+0.81%
SYK price is up +0.81% since January 1st

Price 1-year change

+4.5%
SYK price is up +4.5% year-on-year

Price 3-year change

+34.7%
SYK price is up +34.7% over the past 3 years

Price Range

Price All-time high

$406.19
SYK price is currently -10.64% below its historical high of $406.19

Price 3-year low

$188.84
SYK price is currently +92.21% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$138.50B
SYK market capitalization is $138.50 billion

Market cap 3-year change

+35.92%
SYK market capitalization is up +35.92% over the past 3 years

Market cap All-time high

$154.54B
SYK market capitalization is currently -10.38% below its historical high of $154.54 billion

Market cap sector rank

98.93%
SYK market capitalization is higher than 98.93% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.17%
SYK shares outstanding is up +0.17% year-on-year

Shares Outstanding 3-Year Change

+0.91%
SYK shares outstanding is up +0.91% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.67
SYK beta is 0.67

200-day SMA

$364.25
SYK price is currently -0.35% below its 200-day simple moving average

50-day SMA

$379.01
SYK price is currently -4.23% below its 50-day simple moving average

RSI

47.02
SYK 14-day relative strength index is 47.02

Volume

1.67
SYK 30-day relative volume is 1.67

ATR

$15.92
SYK average true range is $15.92

10-day Historical Volatility

56.10%
SYK 10-day historical volatility is 56.10%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.84
SYK last dividend was $0.84 per share, with an ex-dividend date of March 31, 2025

Next Dividend

-
SYK next dividend has not yet been announced

Dividend per share

Dividend per share

$3.20
SYK annual dividend per share is $3.20

Dividend per share Sector Rank

86.05%
SYK annual dividend per share is higher than 86.05% of companies in Healthcare sector

Dividend per share 1-Year Change

+4.92%
SYK annual dividend per share is up +4.92% year-on-year

Dividend per share 3-Year Change

+23.79%
SYK annual dividend per share is up +23.79% over the past 3 years

Dividend yield

Dividend yield

0.88%
SYK annual dividend yield is 0.88%

Dividend yield Sector Rank

24.71%
SYK annual dividend yield is higher than 24.71% of companies in Healthcare sector

Other

Payout ratio

40.73%
SYK annual payout ratio is 40.73%

Dividends paid

$1.22B
SYK annual dividends paid is $1.22 billion

Free cash flow

$3.49B
SYK annual free cash flow is $3.49 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$22.59B
SYK annual revenue is $22.59 billion

Revenue Analysts estimate

$24.52B
SYK annual revenue is currently -7.87% lower than the consensus analysts' forecast

Revenue 1-year change

+10.23%
SYK annual revenue is up +10.23% year-on-year

Revenue Sector rank

96.64%
SYK annual revenue is higher than 96.64% of companies in Healthcare sector

EPS

EPS

$7.76
SYK annual earnings per share is $7.76

EPS Analysts estimate

$13.48
SYK annual earnings per share is currently -42.42% lower than the consensus analysts' forecast

EPS 1-year change

-5.94%
SYK annual earnings per share is down -5.94% year-on-year

EPS Sector rank

97.61%
SYK annual earnings per share is higher than 97.61% of companies in Healthcare sector

Profit

Gross profit

$14.44B
SYK annual gross profit is $14.44 billion

Gross margin

63.91%
SYK annual gross profit margin is 63.91%

Operating profit

$4.67B
SYK annual operating income is $4.67 billion

Operating margin

20.65%
SYK annual operating profit margin is 20.65%

Net income

$2.99B
SYK annual net profit is $2.99 billion

Net margin

13.25%
SYK annual net profit margin is 13.25%

Expenses

Total expenses

$17.93B
SYK annual total expenses is $17.93 billion

Operating expenses

$9.77B
SYK annual total operating expenses is $9.77 billion

Cost of goods sold

$8.15B
SYK annual cost of goods sold is $8.15 billion

Selling, general & administrative expenses

$7.68B
SYK annual SGA is $7.68 billion

Depreciation and amortization

$1.05B
SYK annual depreciation & amortization is $1.05 billion

Interest expense

-
SYK annual interest expense value is unknown

Income tax

$499.00M
SYK annual income tax is $499.00 million

EBIT & EBITDA

EBIT

$4.67B
SYK annual earnings before interest & taxes is $4.67 billion

EBITDA

$5.72B
SYK annual EBITDA is $5.72 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$42.97B
SYK annual total assets is $42.97 billion

Non current assets

$28.12B
SYK annual long term assets is $28.12 billion

Current assets

$14.85B
SYK annual total current assets is $14.85 billion

Cash and cash equivalents

$3.65B
SYK annual cash & cash equivalents is $3.65 billion

Accounts receivable

$3.99B
SYK annual accounts receivable is $3.99 billion

Inventory

$4.77B
SYK annual inventory is $4.77 billion

Liabilities

Total liabilities

$22.34B
SYK annual total liabilities is $22.34 billion

Long term liabilities

$14.72B
SYK annual total long term liabilities is $14.72 billion

Current liabilities

$7.62B
SYK annual total current liabilities is $7.62 billion

Accounts payable

$1.68B
SYK annual accounts payable is $1.68 billion

Debt

Total debt

$13.60B
SYK annual total debt is $13.60 billion

Total debt 1-year change

+4.63%
SYK annual total debt is up +4.63% year-on-year

Long term debt

$12.19B
SYK annual long term debt is $12.19 billion

Short term debt

$1.41B
SYK annual short term debt is $1.41 billion

Equity & Capital

Shareholders equity

$20.63B
SYK annual stockholders equity is $20.63 billion

Book value

$20.63B
SYK annual book value is $20.63 billion

Retained earnings

$18.53B
SYK annual retained earnings is $18.53 billion

Working capital

$7.23B
SYK annual working capital is $7.23 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$4.24B
SYK annual cash flow from operations is $4.24 billion

Cash from operations 1-year change

+14.31%
SYK annual cash flow from operations is up +14.31% year-on-year

Cash from investing

-$3.00B
SYK annual cash flow from investing activities is -$3.00 billion

Cash from investing 1-year change

-211.85%
SYK annual cash flow from investing activities is down -211.85% year-on-year

Cash from financing

-$525.00M
SYK annual cash flow from financing activities is -$525.00 million

Cash from financing 1-year change

+67.06%
SYK annual cash flow from financing activities is up +67.06% year-on-year

CAPEX

CAPEX

$755.00M
SYK annual capital expenditures is $755.00 million

CAPEX 1-year change

+31.3%
SYK annual capital expenditures is up +31.3% year-on-year

Free Cash Flow

Free cash flow

$3.49B
SYK annual free cash flow is $3.49 billion

Free cash flow 1-year change

+11.19%
SYK annual free cash flow is up +11.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

63.91%
SYK annual gross profit margin is 63.91%

Operating margin

20.65%
SYK annual operating profit margin is 20.65%

Net margin

13.25%
SYK annual net profit margin is 13.25%

ROA & ROE

ROA

7.22%
SYK annual return on assets is 7.22%

ROE

15.26%
SYK annual return on equity is 15.26%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

46.77
SYK price to earnings ratio is 46.77

PE ratio Sector rank

76.96%
SYK price to earnings ratio is higher than 76.96% of companies in Healthcare sector

PB Ratio

PB ratio

6.71
SYK price to book ratio is 6.71

PB ratio Sector rank

88.32%
SYK price to book ratio is higher than 88.32% of companies in Healthcare sector

PS Ratio

PS ratio

6.13
SYK price to sales ratio is 6.13

PS ratio Sector rank

71.54%
SYK price to sales ratio is higher than 71.54% of companies in Healthcare sector

Enterprise value

Enterprise value

$148.45B
SYK enterprise value is $148.45 billion

Enterprise value Sector rank

98.68%
SYK enterprise value is higher than 98.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

26.07
SYK EV/EBITDA is 26.07

EV/EBITDA Sector rank

93.92%
SYK EV/EBITDA is higher than 93.92% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.95
SYK annual current ratio is 1.95

Quick ratio

1.32
SYK annual quick ratio is 1.32

Leverage

Debt to equity

0.59
SYK annual debt to equity ratio is 0.59

Interest coverage ratio

-
SYK annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

7
SYK piotroski f-score is 7

Altman Z-Score

5.41
SYK altman z-score is 5.41

Analyst ratings

Recent major analysts updates

Mar 21, 25 Needham
Buy
Feb 18, 25 JMP Securities
Market Perform
Feb 10, 25 Barclays
Overweight
Jan 30, 25 Truist Securities
Hold
Jan 30, 25 Goldman Sachs
Neutral
Jan 29, 25 Wells Fargo
Overweight
Jan 29, 25 Stifel
Buy
Jan 29, 25 RBC Capital
Outperform
Jan 29, 25 Needham
Buy
Jan 29, 25 JP Morgan
Overweight

Institutional Ownership

Similar stocks

DHR logo
Danaher (DHR)
BSX logo
Boston Scientific (BSX)
GILD logo
Gilead Sciences (GILD)
SNY logo
Sanofi (SNY)
PFE logo
Pfizer (PFE)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
AMGN logo
Amgen (AMGN)
MDT logo
Medtronic (MDT)
BMY logo
Bristol-Myers Squibb (BMY)
  • What is the ticker symbol for Stryker?
  • Does Stryker pay dividends?
  • What sector is Stryker in?
  • What industry is Stryker in?
  • What country is Stryker based in?
  • When did Stryker go public?
  • Is Stryker in the S&P 500?
  • Is Stryker in the NASDAQ 100?
  • Is Stryker in the Dow Jones?
  • When was Stryker's last earnings report?
  • When does Stryker report earnings?
  • Should I buy Stryker stock now?

What is the ticker symbol for Stryker?

The ticker symbol for Stryker is NYSE:SYK

Does Stryker pay dividends?

Yes, Stryker pays dividends. The last payment was $0.84, with an ex-dividend date on March 31, 2025

What sector is Stryker in?

Stryker is in the Healthcare sector

What industry is Stryker in?

Stryker is in the Medical Devices industry

What country is Stryker based in?

Stryker is headquartered in United States

When did Stryker go public?

Stryker's initial public offering (IPO) was on March 17, 1980

Is Stryker in the S&P 500?

Yes, Stryker is included in the S&P 500 index

Is Stryker in the NASDAQ 100?

No, Stryker is not included in the NASDAQ 100 index

Is Stryker in the Dow Jones?

No, Stryker is not included in the Dow Jones index

When was Stryker's last earnings report?

Stryker's most recent earnings report was on Jan 28, 2025

When does Stryker report earnings?

The next expected earnings date for Stryker is May 1, 2025

Should I buy Stryker stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page